MARKET

NSPRZ

Inspiremd
NSPRZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0180
0.0147
0.0022
-
InspireMD Announces Inducement Grants for New Employee
Reuters · 01/20 14:00
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 01/20 14:00
InspireMD Reports C-GUARDIANS Trial Shows Lowest Adverse Event Rates for Carotid Stenting
Reuters · 01/12 14:00
InspireMD Grants Equity Awards and Extended Options to Departing Board Member
Reuters · 12/19/2025 21:16
InspireMD Director Paul Stuka Reports Acquisition of Common Shares
Reuters · 12/11/2025 21:06
INSPIREMD ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 11/21/2025 14:00
InspireMD Q3 revenue beats estimates on commercial launch of CGuard Prime
Reuters · 11/04/2025 12:13
INSPIREMD NAMES PETER A. SOUKAS, M.D., AS CHIEF MEDICAL OFFICER
Reuters · 11/03/2025 12:30
More

Webull offers Inspiremd stock information, including NASDAQ: NSPRZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NSPRZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NSPRZ stock methods without spending real money on the virtual paper trading platform.